A phase 1 study of intermittently administered pazopanib in combination with continuous daily dosing of lapatinib in patients with solid tumors

H. Henary, G. C. George, Jennifer Jane Wheler, A. Naing, S. Piha-Paul, S. Fu, R. Mistry, R. Zinner, R. Kurzrock, D. S. Hong

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1 study of intermittently administered pazopanib in combination with continuous daily dosing of lapatinib in patients with solid tumors'. Together they form a unique fingerprint.

Chemistry

Medicine & Life Sciences